Jumping Genes and Proteomics for New Cancer Therapies: 2019 Distinguished Lecture Series at Sylvester Comprehensive Cancer Center at University of Miami
Read More-
Alex Kentsis
Urine proteomics to discover prognostic biomarkers and improved therapeutic targets for kidney tumors
Discovery of biomarkers for improved precision in oncology remains a critical problem. This is particularly pressing for cancers that currently lack adequate markers for stratification of chemotherapy and targets for…
Read More-
Alex Kentsis
Ultrasensitive pathway-scale functional proteomics using the Quantitative Cell Proteomics Atlas at Single Cell Proteomics 2019
Read More-
Alex Kentsis
Is it possible to use cross-linking mass spectrometry to identify protein-protein interactions in living cells?
Cross-linking mass spectrometry is a powerful tool to elucidate protein-protein interactions and macromolecular structure based on cross-linker distances between specific amino acid residues. In a recent study led by Zheng…
Read More-
Alex Kentsis
UltraQuant: Open framework for running MaxQuant mass spectrometry proteomics algorithms on Linux computer clusters
While computational genomics methods have been greatly advanced by open development in distributed computing environments, computational tools for mass spectrometry proteomics remain tethered to proprietary and often outdated operating systems.…
Read More-
Alex Kentsis
Twitter Feed
Load More...How do DNA-binding proteins engage specific sites “hidden” in chromatin? Recent cryoEM studies shed light on mechanisms @KurumizakaLab @CramerLab TaipaleLab, @SchubelerLab @LabThoma
https://authors.elsevier.com/a/1dGBbL7PXe%7Eh%7EProteomics folks, we are trying to look for mass spectral evidence of branched peptides, where fragment spectra may content a large lysine adduct and many will be chimeric from co-fragmentation of branches. 1/n
Happy birthday to Nobel laureate Dr. Barbara McClintock! 🎉🎂 Learn more about this pioneer who pushed on with her research in the face of every challenge, saying, “They said I was crazy—absolutely mad...When you know you are right you don’t care!” https://www.cshl.edu/barbara-mcclintock-free-to-discover/
Out today in Clinical Cancer Research (@CCR_AACR ), our preclinical study of combined JAK, CDK4/6, and PIM kinase inhibitors in MPN. https://clincancerres.aacrjournals.org/content/27/12/3456 @MSKEducation @MSKCC_Library @akrish0294 @rosslevinemd @RichardKoche @ShoronMowla @RossLevineLab #mpnsm
